Findings presented this week at the American College of Rheumatology Annual Meeting in Boston suggest that patients with end-stage lung disease due to systemic sclerosis should not simply be denied lung transplantation because of short- and long-term survival concerns. Systemic sclerosis (SSc), also known as scleroderma, is a disease affecting the skin and other organs of the body. It is an autoimmune rheumatic disease, meaning that the body''s immune system is ...Sunday 16 November 2014
Survival in Systemic Sclerosis Patients Following Lung Transplantation Evaluated in Large Study
Findings presented this week at the American College of Rheumatology Annual Meeting in Boston suggest that patients with end-stage lung disease due to systemic sclerosis should not simply be denied lung transplantation because of short- and long-term survival concerns. Systemic sclerosis (SSc), also known as scleroderma, is a disease affecting the skin and other organs of the body. It is an autoimmune rheumatic disease, meaning that the body''s immune system is ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment